Similar articles for PMID: 22220986

Year	Number of Results
2002	4
2003	1
2004	1
2005	2
2006	1
2007	5
2008	3
2009	4
2010	8
2011	7
2012	13
2013	8
2014	7
2015	12
2016	8
2017	7
2018	8
2019	6
2020	3
2021	2
2022	6
2024	0

1

Bendamustine: more ammunition in the battle against mantle cell lymphoma.

Chang JE, Kahl BS. Chang JE, et al. Leuk Lymphoma. 2012 Jul;53(7):1249-50. doi: 10.3109/10428194.2011.654342. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22220986 No abstract available.

2

[Mechanisms of action and clinical effectiveness of the newly approved anti-cancer drug bendamustine].

Furukawa Y, Hiraoka N, Wada T, Kikuchi J, Kano Y. Furukawa Y, et al. Nihon Yakurigaku Zasshi. 2011 Jul;138(1):26-32. doi: 10.1254/fpj.138.26. Nihon Yakurigaku Zasshi. 2011. PMID: 21747206 Review. Japanese. No abstract available.

3

HBV reactivation in malignant lymphoma patients treated with rituximab and bendamustine.

Tsutsumi Y, Ogasawara R, Miyashita N, Tanaka J, Asaka M, Imamura M. Tsutsumi Y, et al. Int J Hematol. 2012 May;95(5):588-91. doi: 10.1007/s12185-012-1050-9. Epub 2012 Mar 16. Int J Hematol. 2012. PMID: 22419099 Free article. No abstract available.

4

A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.

Warsch S, Hosein PJ, Maeda LS, Alizadeh AA, Lossos IS. Warsch S, et al. Leuk Lymphoma. 2012 Jul;53(7):1299-1305. doi: 10.3109/10428194.2011.649476. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22185662 Free PMC article.

5

Bendamustine: a review of its use in the management of indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

Garnock-Jones KP. Garnock-Jones KP. Drugs. 2010 Sep 10;70(13):1703-18. doi: 10.2165/11205860-000000000-00000. Drugs. 2010. PMID: 20731477 Review.

6

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma.

Friedberg JW, Vose JM, Kelly JL, Young F, Bernstein SH, Peterson D, Rich L, Blumel S, Proia NK, Liesveld J, Fisher RI, Armitage JO, Grant S, Leonard JP. Friedberg JW, et al. Blood. 2011 Mar 10;117(10):2807-12. doi: 10.1182/blood-2010-11-314708. Epub 2011 Jan 14. Blood. 2011. PMID: 21239695 Free PMC article. Clinical Trial.

7

[II. Treatment trend and outlook on bendamustine for mantle cell lymphoma and follicular lymphoma].

Ogura M. Ogura M. Gan To Kagaku Ryoho. 2012 May;39(5):736-42. Gan To Kagaku Ryoho. 2012. PMID: 22701900 Japanese. No abstract available.

8

Cryoglobulins mimicking platelet recovery in a mantle cell lymphoma patient treated with chemoimmunotherapy.

Herishanu Y, Katz BZ. Herishanu Y, et al. Blood. 2015 Feb 5;125(6):1047. doi: 10.1182/blood-2014-11-614008. Blood. 2015. PMID: 25802907 Free article. No abstract available.

9

Bendamustine for patients with indolent B cell lymphoid malignancies including chronic lymphocytic leukaemia.

Vidal L, Gafter-Gvili A, Gurion R, Raanani P, Dreyling M, Shpilberg O. Vidal L, et al. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009045. doi: 10.1002/14651858.CD009045.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972131 Free PMC article. Review.

10

Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.

Ogura M, Uchida T, Taniwaki M, Ando K, Watanabe T, Kasai M, Matsumoto Y, Shimizu D, Ogawa Y, Ohmachi K, Yokoyama H, Tobinai K; Japanese Bendamustine Lymphoma Study Group. Ogura M, et al. Cancer Sci. 2010 Sep;101(9):2054-8. doi: 10.1111/j.1349-7006.2010.01633.x. Cancer Sci. 2010. PMID: 20594195 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year